Quest Diagnostics Reports Strong Q1 Earnings and Raises 2026 Guidance
Quest Diagnostics reported Q1 2026 revenue of $2.9 billion, up 9.2% YoY, and raised its 2026 revenue guidance to $11.78–11.90 billion. The company also noted strong contributions from collaborations with Fresenius Medical Care and Corewell Health, though it expects near-term costs from AI initiatives and fuel expenses to impact EPS.
Topics: AI Implementation Collaborations Cost Pressures Earnings Guidance Upgrade Revenue Growth